Payne and co-workers synthesized tumor vaccines containing per-glycosylated MUC1 glycopeptide and lipopeptide of Pam3CS with an efficient condensation reaction, and they demonstrated that different glycosylations affected the immune response [37]. This evidence concerns the gene MUC1 and neoplasm.